Recurrent Ovarian Cancer Clinical Trials in Louisville, Kentucky
2 recruitingLouisville, Kentucky
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression
Recurrent Ovarian CancerFolate Receptor-Alpha Positive
AbbVie100 enrolled40 locationsNCT06365853
Recruiting
Phase 1Phase 2
Combination Therapy for Recurrent Ovarian Cancer
Recurrent Ovarian Cancer
Sham Sunder Kakar72 enrolled1 locationNCT05610735